| 1 |
Ferraro L, Antonelli T, O'Connor WT, et al., Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol Psychiatry. 1997; 42: 1181-1183.
DOI
ScienceOn
|
| 2 |
Amiri S, Mohammadi MR, Mohammadi M, et al., Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. Prog Neuropsychopharmacol Biol og Psychiatry. 2008; 32: 145-149.
DOI
ScienceOn
|
| 3 |
American Academy of Pediatrics. Committee on Quality Improvement, Subcommittee on ADHD. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics. 2000; 105: 1158-1170.
DOI
ScienceOn
|
| 4 |
Kelsey DK, Sumner CR, Casat CD, et al., Once-daily atomoxetine treatment for children with attention-deficit/ hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebocontrolled trial. Pediatrics. 2004; 114: e1-e8.
DOI
ScienceOn
|
| 5 |
Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol. 2000 ;10: 311-320.
DOI
ScienceOn
|
| 6 |
Biederman J, Swanson JM, Wigal SB, et al., Efficacy and safety of modafinil film-coated tablets in children and adolescents with attentiondeficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics. 2005; 116: e777-e784.
DOI
ScienceOn
|
| 7 |
Robertson PJr, Hellriegel ET. Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet. 2003; 42: 123- 137.
DOI
ScienceOn
|
| 8 |
Wigal SB, Biederman J, Swanson JM, et al., Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies. Prim Care Companion J Clin Psychiatry. 2006; 8: 352-360.
|
| 9 |
Kahbazi M, Ghoreishi A, Rahiminejad F, et al., A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Psychiatry Res. 2009; 168: 234-237.
DOI
ScienceOn
|
| 10 |
Turner DC, Clark L, Dowson J, et al., Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 2004; 55: 1031-1040.
DOI
ScienceOn
|
| 11 |
Engber TM, Koury EJ, Dennis SA, et al., Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neurosci Lett. 1998; 241: 95-98.
DOI
|
| 12 |
Provigil prescribing information. Cephalon, Inc. 2004.
|
| 13 |
Lin JS, Roussel B, Akaoka H, et al., Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res. 1992; 591: 319-326.
DOI
ScienceOn
|
| 14 |
Lin J-S, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA. 1996; 93: 14128-14133.
DOI
ScienceOn
|
| 15 |
Birnbaum HG, Kessler RC, Lowe SW. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin. 2005; 21: 195-206.
DOI
ScienceOn
|
| 16 |
Brown RT, Amler RW, Freeman WS, et al., Gender effects on attention-deficit/hyperactivity disorder in adults, revisited. Pediatrics. 2005; 115: e749-e757.
DOI
ScienceOn
|
| 17 |
Myrick H, Malcolm R, Taylor B, et al., Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues. Ann Clin Psychiatry. 2004; 16: 101-109.
DOI
ScienceOn
|
| 18 |
Michelson D, Allen AJ, Busner J, et al., Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry. 2002; 159: 1896-1901.
DOI
ScienceOn
|
| 19 |
Biederman J, Spencer T, Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2004; 7: 77-97.
DOI
ScienceOn
|
| 20 |
Rugino TA, Samsock TC. Modafinil in children with attention-deficit hyperactivity disorder. Pediatr Neurol. 2003; 29: 136-142.
DOI
ScienceOn
|
webmaster
